Reports for TEVA-SUCRALFATE
Brand name
TEVA-SUCRALFATE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02045702 |
Ingredients
SUCRALFATE |
Ingredient Strength
1 G |
ATC Code
A02BXA02BX |
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-SUCRALFATE | 100 | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
TEVA-SUCRALFATE | 100 | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
TEVA-SUCRALFATE | 100 | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
TEVA-SUCRALFATE | 100 | Resolved | 2022-01-27 | 2022-02-25 | 153727 |
TEVA-SUCRALFATE | 100 | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
TEVA-SUCRALFATE | 100 | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
TEVA-SUCRALFATE | 100 | Resolved | 2024-03-07 | 2024-05-30 | 221540 |
TEVA-SUCRALFATE | 500 | Resolved | 2019-08-29 | 2020-01-30 | 92663 |
TEVA-SUCRALFATE | 500 | Resolved | 2020-07-23 | 2020-08-21 | 120890 |
TEVA-SUCRALFATE | 500 | Resolved | 2020-09-24 | 2020-10-15 | 124995 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0